Targeting the c-Met signaling pathway by humanized anti-HGF antibody inhibits irinotecan resistance in colorectal cancer.

被引：0
|
作者：
Woo, Jong Kyu [1 ]
Jang, Yeong-Su [1 ]
Kang, Ju-Hee [1 ]
Kim, Hwan Mook [1 ]
Oh, Seung-Hyun [1 ]
机构：
[1] Gachon Univ, Inchon, South Korea
来源：
CANCER RESEARCH | 2015年 / 75卷 / 01期
关键词：
D O I：
10.1158/1538-7445.CHTME14-A61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A61
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer: Importance of Targeting c-MET and HGF Interaction
    Youngjoo Kwon
    Andrew K. Godwin
    Reproductive Sciences, 2017, 24 : 494 - 501
  • [22] Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer: Importance of Targeting c-MET and HGF Interaction
    Kwon, Youngjoo
    Godwin, Andrew K.
    REPRODUCTIVE SCIENCES, 2017, 24 (04) : 494 - 501
  • [23] Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib
    Kim, Junyeol
    Lee, Tae Seung
    Lee, Myeong Hwan
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Sang Hyub
    Paik, Woo Hyun
    CANCERS, 2024, 16 (05)
  • [24] Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression
    Noriega-Guerra, Heydi
    Freitas, Vanessa Morais
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [25] Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
    Albadari, Najah
    Xie, Yang
    Li, Wei
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [26] Inhibiting endothelium directed tumor cell streaming by targeting the HGF/C-Met signaling pathway.
    Leung, E.
    Xue, A.
    Wang, Y.
    Rougerie, P.
    Sharma, V. P.
    Eddy, R. J.
    Cox, D.
    Condeelis, J. S.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [27] The role of c-MET/HGF signaling as a critical mediator of an invasive and resistant phenotype in colorectal cancer
    Bradley, Conor A.
    Dunne, Philip
    McArt, Darragh
    Arthur, Ken
    McQuaid, Stephen
    Salto-Tellez, Manuel
    Johnston, Patrick
    Van Schaeybroeck, Sandra
    CANCER RESEARCH, 2015, 75
  • [28] The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
    Varkaris, Andreas
    Corn, Paul G.
    Gaur, Sanchaika
    Dayyani, Farshid
    Logothetis, Christopher J.
    Gallick, Gary E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (12) : 1677 - 1684
  • [29] Tumor-associated Macrophages Mediate Gefitinib Resistance in Lung Cancer through HGF/c-met Signaling Pathway
    Tang, Xiali
    Chen, Yu
    Jiao, Demin
    Liu, Xiang
    Chen, Jun
    Liu, Yongyang
    Jiang, Chunyan
    Chen, Qingyong
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (01) : 30 - 38
  • [30] The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
    Hu, Chi-Tan
    Wu, Jia-Ru
    Cheng, Chuan-Chu
    Wu, Wen-Sheng
    CANCERS, 2017, 9 (06):
12345